Clinical Trial Update: Pegfilgrastim PBPC Mobilization Study [Phase 2]

View source ↗

Summary

Completed Phase 2 clinical trial sponsored by Amgen evaluating pegfilgrastim for peripheral blood progenitor cell mobilization in patients with lymphoma, includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Lymphoma, Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED